Study to Assess the Safety of Repeat Administration of FX006 Administered to Patients With Osteoarthritis of the Knee
NCT03046446
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
208
Enrollment
INDUSTRY
Sponsor class
Conditions
Osteoarthritis of the Knee
Interventions
DRUG:
FX006 32 mg
Sponsor
Pacira Pharmaceuticals, Inc